The Smithsonian’s National Museum of American History lists First Do No Harm as on view. Its November 6 announcement describes an exhibition of medical invention, public health, and the people whose needs have challenged both. The artifacts include an early artificial heart, a penicillin mold sample, HIV and AIDS medicines, and a mosquito net used after Hurricane Maria. Objects can show what people made. The harder question is who could receive care, and who had to create it when the established system refused.
The exhibition opens with three stories. Maurice Hilleman helped develop about 40 vaccines. A 1985 federal report acknowledged racial and ethnic health disparities in the United States. In 1899, San Francisco’s Chinese Benevolent Association established the Tung Wah Dispensary for a community excluded from the city’s hospitals. These are different kinds of action: research, public accounting, and a community creating access. Their placement together asks visitors to look at medical progress from the point of view of a patient who might still be turned away.
That 1899 dispensary deserves particular attention. The museum’s account gives its founding and purpose; it does not supply a patient’s private experience or a complete history of the institution. Still, the stated reason for its creation is plain enough. The people who established it did not wait for a history of exclusion to become comfortable to discuss. They organized a place where neighbors could seek care. Their work adds a person to the story of medicine before it adds a display object.
The 1985 report marks another kind of change. Once a government names a disparity, its public record becomes harder to reconcile with a story that treats access as a solved problem. Acknowledgment can inform better decisions. It does not, by itself, make a clinician available, repair trust, or tell a patient whether treatment is affordable. The exhibition’s arrangement allows both the advance and the unfinished obligation to remain visible.
Medical history is often told through a sequence of breakthroughs. A new tool makes possible what was once impossible. That story is true, and it matters. A patient also needs the tool to reach them, a practitioner who listens, and institutions willing to recognize where their practice falls short. A celebrated device can sit beside the record of a community that had to build its own clinic. Neither story erases the other.
The museum says the exhibition is planned for about three years. Visitors may leave admiring a vaccine or a scanner. They might also begin asking which people were absent when a medical system defined its normal patient. That question can change what a museum collects and what a healthcare organization measures, though this exhibition alone cannot demonstrate such a change.
There are two ways to tell the next chapter. We can keep praising invention while treating unequal access as a footnote. Or we can ask who still has to organize care outside the usual route, then put those people’s knowledge beside the devices and discoveries we admire. The second path asks more of researchers, institutions, and visitors. It also gives progress a more honest measure: whether a person can actually receive the care made possible.
If you visit a medical exhibition, pause at the community story as long as you pause at the instrument. Ask who made care available and who could decide how it was offered. That is a useful question to bring home to a hospital, a workplace, or a city meeting.
These readings use Pete Gall's frameworks to help us see people more clearly and attend to God at work in a world that can feel hostile, yet remains a place of His delight. Explore the framework behind this article.
Val is an AI editorial assistant working with Pete Gall.